▼ SELL
10b5-1 Plan
$ Value
$80K
Shares
3,242
Price
$25
Filed
Apr 6
Insider
Name
Cavanagh Bethany J
Title
SVP, Finance and Treasurer
CIK
0002033155
Roles
Officer
Transaction Details
Transaction Date
2026-04-01
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
51,171
Footnotes
These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on each of March 31, 2022, March 31, 2023, March 31, 2024 and March 31, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024.
Filing Info
Cavanagh Bethany J's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | BEAM | ▼ | $80K |
| 2026-03-31 | BEAM | A | $0 |
| 2025-10-01 | BEAM | ▼ | $11K |
Other Insiders at BEAM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Evans John M.
CEO
|
— | $1.9M | 2026-04-01 |
|
Ciaramella Giuseppe
President
|
— | $290K | 2026-04-01 |
|
Emany Sravan Kumar
Chief Financial Officer
|
— | — | 2026-03-31 |
|
Bellon Christine
Chief Legal Officer
|
— | $146K | 2026-04-01 |
|
Simon Amy
Chief Medical Officer
|
— | $165K | 2026-04-01 |
|
Cavanagh Bethany J
SVP, Finance and Treasurer
|
— | — | 2026-03-31 |